11 January 2019 - Needs parliament clearance before 29 March.
As Tuesday's crucial Commons' vote on the Brexit deal approaches, it's clear that Parliament is running out of time to pass any legislation which would allow the MHRA to function in the even of a no deal Brexit.
The UK’s medicine regulator issued its plans for a no deal Brexit last week, saying it has drawn up a “robust plan to make sure [the UK’s] regulatory processes for medicines, clinical trials and medical devices are fit for purpose on exit day”.